Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.
Gladstone researcher Alex Pico helped develop a new way to measure the difference one discovery can make on science around the world.
Are you a passionate undergraduate student pursuing a career in science? Learn why the PUMAS internship might be the right fit for you.
New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer’s disease and Dravet syndrome.
A native of Germany, Melanie trained as a physician before her first-hand experience caring for AIDS patients inspired her dive into biomedical research to discover new ways to fight the virus.
View highlights from Gladstone's 40th year!
Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.
Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.
Fall cohort of five new Gladstone Foundation Board members brings expertise from biotech, venture capital, asset management, and real estate industries
Katherine Pollard, PhD, new director of UCSF’s graduate program in biological and medical informatics, will prioritize teamwork, mentoring, and ties with UC Berkeley.
Gladstone prepares for the future of discovery science with the launch of new strategic plan.
Zak describes how he used to pretend he hated math, and how grad school is teaching him more than just science.
New collaboration will support translation of research discoveries into antiviral therapies
The Center for iPS Cell Research and Application (CiRA) at Kyoto University opened a new on-site laboratory at Gladstone Institutes.
Gladstone scientists are taking a variety of approaches to find a cure for HIV.
Gladstone researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.
New study shows how patterns in brain activity can be an early predictor of Alzheimer’s symptoms.
Gordon Keller, recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize, discusses challenges and successes during his 30 years of pioneering research on stem cells.
These tiny versions of the heart, brain, intestine, lungs, and other organs are transforming how we research human disease and development at Gladstone and beyond.
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
Gladstone Institutes and Xyphos Biosciences have shown that a cell-based immunotherapy, convertibleCAR®, can reduce the latent reservoir of virus in HIV-infected patients on anti-retroviral therapy
September 16–September 20, 2019, was the 10th Annual National Postdoc Appreciation Week!
On National Coming Out Day, four scientists at Gladstone explain what the day means to them and why it’s important to create an open and inclusive environment.
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem cells (hiPS cells), Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.